Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism
Condition(s):Parkinson Disease; Multiple System Atrophy; Progressive Supranuclear PalsyLast Updated:March 2, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Parkinson Disease; Multiple System Atrophy; Progressive Supranuclear PalsyLast Updated:March 2, 2022Withdrawn
Condition(s):Hypotension, Orthostatic; Hypotension; Spinal Cord InjuriesLast Updated:June 26, 2023Completed
Condition(s):Spinal Cord Injury; HypotensionLast Updated:July 30, 2013Completed
Condition(s):Menkes Disease; Occipital Horn SyndromeLast Updated:January 10, 2023Recruiting
Condition(s):Primary Autonomic Failure; Dopamine Beta Hydroxylase Deficiency; Non-Diabetic Neuropathy; Neurogenic Orthostatic HypotensionLast Updated:February 9, 2024Completed
Condition(s):Parkinson’s DiseaseLast Updated:June 25, 2018Completed
Condition(s):Symptomatic Neurogenic Orthostatic Hypotension; Parkinson’s Disease; Multiple Systems Atrophy; Pure Autonomic Failure; Dopamine Beta Hydroxylase DeficiencyLast Updated:January 8, 2016Terminated
Condition(s):Gait Disorders, NeurologicLast Updated:March 29, 2013Withdrawn
Condition(s):Chronic Fatigue Syndrome; Orthostatic Hypotension; Neurally Mediated Hypotension; Neurogenic Orthostatic HypotensionLast Updated:June 9, 2014Terminated
Condition(s):Autonomic Failure; Pure Autonomic Failure; Multiple System Atrophy; Parkinson Disease; Orthostatic HypotensionLast Updated:March 26, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.